These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6086215)

  • 1. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
    Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
    Schrinner E; Limbert M; Seeger K; Seibert G; Novick WJ
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
    Neu HC
    Rev Infect Dis; 1982; 4 Suppl():S374-8. PubMed ID: 6294786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
    Jones RN; Barry AL; Packer RR
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
    Aldridge KE; Sanders CV; Marier RL
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime.
    Quintiliani R; Nightingale CH; Tilton R
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):63S-70S. PubMed ID: 6086220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro synergy between cefotaxime and its main metabolite, desacetylcefotaxime].
    Kobayashi S; Arai S; Hayashi S; Sakaguchi T; Kawana R
    Jpn J Antibiot; 1988 May; 41(5):594-601. PubMed ID: 3216482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and beta-lactamase stability.
    Limbert M; Seibert G; Schrinner E
    Infection; 1982; 10(2):97-100. PubMed ID: 6284653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.
    Jones RN; Barry AL; Thornsberry C
    Rev Infect Dis; 1982; 4 Suppl():S366-73. PubMed ID: 6294785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro study of the interaction between cefotaxime and desacetylcefotaxime.
    Winstanley TG; Spencer RC
    Drugs Exp Clin Res; 1986; 12(12):967-71. PubMed ID: 3471432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1980 Apr; 17(4):583-90. PubMed ID: 6967294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides species.
    Canawati HN
    Diagn Microbiol Infect Dis; 1989; 12(1):33-7. PubMed ID: 2714070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test.
    Reller LB
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.
    Aldridge KE
    Diagn Microbiol Infect Dis; 1989; 12(1):45-50. PubMed ID: 2714072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTX and its desacetyl derivative (des-CTX): interaction with some representative beta-lactamases and their related pattern of resistance to newer selected clinical isolates.
    Amicosante G; Perilli M; Felici A; Segatore B; Franceschini N; Basani F; Di Girolamo M; Oratore A
    Drugs Exp Clin Res; 1990; 16(11):549-56. PubMed ID: 2101778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime.
    Molinari G; Saverino D; Paglia P; Debbia EA; Schito GC
    J Chemother; 1991 Feb; 3(1):6-12. PubMed ID: 2019866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
    Oizumi K; Hayashi I; Aonuma S; Konno K
    Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN; Wilson HW
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
    Jones RN; Barry AL; Thornsberry C
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes.
    Smith JA; Henry D; Ngui-Yen J; Castell A; Coderre S
    J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.